Its because the FDA approval of a GLP-1 agonist often affects whether and how your insurance will cover the drug when its prescribed to you
For example, it as like an electrical switch that turns genes on and off
The Ozempic lawsuit, filed against pharmaceutical giants Novo Nordisk and Eli Lilly, alleged that the drugs, both Glucagon-like peptide 1 (GLP-1) agonists, caused severe gastrointestinal issues.
A differential diagnosis for a pigmented lesion may include traumatic, reactive, neoplastic, and systemic pathologies
They are water-soluble which just means that if there's anything in excess, it will be just excreted through urine or bile
Its not officially listed as a common side effect, but many people do report low energy during treatmentespecially early on or after dose increases